Form 4: Agios Pharmaceuticals Officer Reports Stock Transactions

Theodore James Jr. Washburn, Principal Accounting Officer of Agios Pharmaceuticals, reports acquisition and disposal of common stock and restricted stock units.

Summary

• Theodore James Jr. Washburn, a Principal Accounting Officer at Agios Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Washburn acquired 777 shares and 2,350 shares of common stock through the vesting of restricted stock units, and also acquired 7,350 restricted stock units.
• On March 5, 2024, Washburn sold 295 shares and 919 shares of common stock at a price of $32.57 per share to cover tax withholding obligations.
• Following these transactions, Washburn directly owns 4,799 shares of common stock and 4,700 restricted stock units.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it primarily reports routine stock transactions by a company officer. The transactions are related to vesting and tax obligations, which are typical occurrences.

Positives

• The granting of restricted stock units to a key officer aligns their interests with the long-term performance of the company.
• The use of a 10b5-1(c) trading plan demonstrates compliance with insider trading regulations.

Future Outlook

The restricted stock units granted on March 1, 2024, will vest in three equal annual installments beginning on March 1, 2025.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among corporate executives to manage stock sales and avoid accusations of insider trading.
• The vesting schedules for restricted stock units are typical, often spanning three to four years with annual or quarterly vesting intervals.
• Comparing the size of the restricted stock unit grants to those of executives at comparable pharmaceutical companies would provide further context.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.

Key Dates